Related Experiment Video

Updated: Aug 26, 2025

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.3K

Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine

Xing Huang1,2,3,4,5, Gang Zhang6,7,8,9,10, Tian-Yu Tang6,7,8,9,10

  • 1Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China. huangxing66@zju.edu.cn.

Military Medical Research
|October 12, 2022
PubMed

Insights

Pancreatic cancer treatment faces challenges due to tumor heterogeneity. Messenger RNA (mRNA) vaccines show promise for personalized pancreatic cancer therapy, offering advantages over conventional approaches.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Pancreatic cancer exhibits significant inter- and intra-tumoral heterogeneity, leading to therapeutic resistance.
  • Conventional treatments for pancreatic cancer often prove insufficient due to tumor complexity.
  • The need for personalized, precise treatment strategies is critical for improving patient outcomes.

Purpose of the Study:

  • To review current advancements in pancreatic cancer vaccines.
  • To highlight the advantages of messenger RNA (mRNA) vaccines over traditional vaccine types.
  • To propose strategies for developing and implementing personalized mRNA vaccines for pancreatic cancer.

Main Methods:

  • Review of existing literature on pancreatic cancer vaccines.
  • Comparative analysis of different vaccine modalities (cellular, microbial, exosomal, protein, peptide, DNA).
  • Evaluation of messenger RNA (mRNA) vaccine technology for pancreatic cancer.

Main Results:

  • Conventional pancreatic cancer vaccines have shown limited efficacy.
  • Messenger RNA (mRNA) vaccines offer technical and conceptual advancements for personalized treatment.
  • mRNA vaccines present a potentially cutting-edge therapeutic option for pancreatic cancer.

Conclusions:

  • Messenger RNA (mRNA) vaccines represent a superior platform for personalized pancreatic cancer treatment.
  • Further research and strategic design are needed to optimize personalized mRNA vaccine application.
  • mRNA vaccines hold significant potential to overcome current therapeutic limitations in pancreatic cancer.
Keywords:
Cancer vaccineImmune subtypePancreatic cancerPrecise therapyTumor antigenmRNA vaccine

More Related Videos

Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection05:49

Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection

Published on: November 1, 2021

3.2K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

740

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
488
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
195